Abstract

Identify, characterize and attempt to develop as potential therapeutics human monoclonal antibodies (hmAbs) and engineered human antibody domains against several microbes on NIAID's list of category A or C pathogens.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
NIH Intra-Agency Agreements (Y02)
Project #
Y2AI9456-2-0-2
Application #
8051101
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2010
Total Cost
$133,000
Indirect Cost

  Institution

Name
National Institute of Allergy and Infectious Diseases
Department
Type
DUNS #
City
State
Country
Zip Code